Trial in Progress of Engot-Cx8/Gog-3024/Innovatv 205: Addition of A New Cohort Using First-Line Tisotumab Vedotin Plus Pembrolizumab Plus Carboplatin +/- Bevacizumab in Recurrent/Metastatic Cervical Cancer

No Thumbnail Available

Files

ae30.pdf (56.69 KB)

Date

2022

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://ijgc.bmj.com/content/ijgc/32/Suppl_3/A225.1.full.pdf
 http://hdl.handle.net/11727/10659

Collections

Tıp Fakültesi / Faculty of Medicine

Endorsement

Review

Supplemented By

Referenced By